|
OMIM |
Link |
Information gain |
01 |
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.011952
|
|
|
IGAN1
|
[NCBI]
|
0.00618478
|
|
|
SLE
|
[NCBI]
|
0.00477733
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.00366223
|
|
|
lobular glomerulopathy, familial
|
[NCBI]
|
0.00235215
|
|
|
LPG
|
[NCBI]
|
0.00222593
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
0.00141844
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.00117279
|
|
|
oculorenocerebellar syndrome
|
[NCBI]
|
0.00117279
|
|
|
ATS
|
[NCBI]
|
0.000977969
|
|
|
SDC2
|
[NCBI]
|
0.000840122
|
|
|
BFH
|
[NCBI]
|
0.000787831
|
|
|
hypokalemia, familial
|
[NCBI]
|
0.000746797
|
|
|
NPHS1
|
[NCBI]
|
0.000708747
|
|
|
NPPA
|
[NCBI]
|
0.000696505
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000616266
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
0.000608298
|
|
|
NPS
|
[NCBI]
|
0.000578588
|
|
|
goodpasture syndrome
|
[NCBI]
|
0.000510386
|
|
|
osteolysis, hereditary, of carpal bones with nephropathy
|
[NCBI]
|
0.000454233
|
|
|
nephrosialidosis
|
[NCBI]
|
0.00044617
|
|
|
CF
|
[NCBI]
|
0.000425233
|
|
|
RA
|
[NCBI]
|
0.000374487
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
0.000372129
|
|
|
VEGF
|
[NCBI]
|
0.000351152
|
|
|
CD2AP
|
[NCBI]
|
0.000348433
|
|
|
NPHP1
|
[NCBI]
|
0.000283203
|
|
|
NPHS1
|
[NCBI]
|
0.000264729
|
|
|
COL4A3
|
[NCBI]
|
0.000254778
|
|
|
denys-drash syndrome
|
[NCBI]
|
0.000254417
|
|
|
PCNA
|
[NCBI]
|
0.000249712
|
|
|
SRN1
|
[NCBI]
|
0.000236433
|
|
|
amyloidosis, familial visceral
|
[NCBI]
|
0.00021215
|
|
|
FSGS2
|
[NCBI]
|
0.00021215
|
|
|
PTPRO
|
[NCBI]
|
0.000201637
|
|
|
aHUS
|
[NCBI]
|
0.000199018
|
|
|
pierson syndrome
|
[NCBI]
|
0.000182837
|
|
|
FSGS1
|
[NCBI]
|
0.000172556
|
|
|
CTGF
|
[NCBI]
|
0.000164839
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
0.000163919
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000149518
|
|
|
CTNS
|
[NCBI]
|
0.000146409
|
|
|
mesangial sclerosis, diffuse renal, with ocular abnormalities
|
[NCBI]
|
0.000145137
|
|
|
spastic paraplegia, sensorineural deafness, mental retardation, and progressive nephropathy
|
[NCBI]
|
0.000145137
|
|
|
ALGS2
|
[NCBI]
|
0.000145137
|
|
|
FSGS3
|
[NCBI]
|
0.000145137
|
|
|
nail-patella-like renal disease
|
[NCBI]
|
0.000145137
|
|
|
ENPEP
|
[NCBI]
|
0.000139926
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
0.000132281
|
|
|
MBL2
|
[NCBI]
|
0.000128184
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
0.000125676
|
|
|
SLSN1
|
[NCBI]
|
0.000118435
|
|
|
COL4A4
|
[NCBI]
|
0.000118296
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
0.000106029
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
0.000106029
|
|
|
biliary malformation with renal tubular insufficiency
|
[NCBI]
|
0.000106029
|
|
|
NGFB
|
[NCBI]
|
0.00010547
|
|
|
AVP
|
[NCBI]
|
0.000101277
|
|
|
NPHS2
|
[NCBI]
|
0.000100766
|
|
|
MADD
|
[NCBI]
|
9.90325e-05
|
|
|
LRP2
|
[NCBI]
|
9.19081e-05
|
|
|
mucopolysaccharidoses, unclassified types
|
[NCBI]
|
9.1373e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
9.1373e-05
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
9.1373e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
9.1373e-05
|
|
|
LAMB2
|
[NCBI]
|
8.38332e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
8.26755e-05
|
|
|
TINU
|
[NCBI]
|
8.19147e-05
|
|
|
CSA
|
[NCBI]
|
7.87293e-05
|
|
|
NPY
|
[NCBI]
|
7.08796e-05
|
|
|
EHBA
|
[NCBI]
|
6.93892e-05
|
|
|
PRL
|
[NCBI]
|
6.93456e-05
|
|
|
MPO
|
[NCBI]
|
6.81325e-05
|
|
|
GLYS1
|
[NCBI]
|
6.48141e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
6.48141e-05
|
|
|
ALB
|
[NCBI]
|
6.16787e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
6.09219e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
5.75401e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
5.50123e-05
|
|
|
TTP
|
[NCBI]
|
5.45547e-05
|
|
|
ACHE
|
[NCBI]
|
5.43362e-05
|
|
|
amyloidosis v
|
[NCBI]
|
5.18858e-05
|
|
|
PODXL
|
[NCBI]
|
5.10274e-05
|
|
|
TRPC6
|
[NCBI]
|
4.91146e-05
|
|
|
FBS
|
[NCBI]
|
4.72811e-05
|
|
|
CLN2
|
[NCBI]
|
4.72811e-05
|
|
|
WT1
|
[NCBI]
|
4.65102e-05
|
|
|
VIP
|
[NCBI]
|
4.60499e-05
|
|
|
ACE
|
[NCBI]
|
4.32939e-05
|
|
|
APOE
|
[NCBI]
|
4.24889e-05
|
|
|
junctional adhesion molecule 4
|
[NCBI]
|
4.16404e-05
|
|
|
PODN
|
[NCBI]
|
4.16404e-05
|
|
|
LMX1B
|
[NCBI]
|
4.01888e-05
|
|
|
fabry disease
|
[NCBI]
|
3.85418e-05
|
|
|
F3
|
[NCBI]
|
3.84119e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
3.71843e-05
|
|
|
MCP
|
[NCBI]
|
3.70355e-05
|
|
|
OCRL
|
[NCBI]
|
3.58616e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
3.46135e-05
|
|
|
UGB
|
[NCBI]
|
3.26085e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
3.23139e-05
|
|
|
PAX2
|
[NCBI]
|
3.14796e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
3.02391e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
3.02391e-05
|
|
|
ILK
|
[NCBI]
|
2.92694e-05
|
|
|
KIRREL
|
[NCBI]
|
2.79329e-05
|
|
|
KIRREL2
|
[NCBI]
|
2.79329e-05
|
|
|
PTPRQ
|
[NCBI]
|
2.79329e-05
|
|
|
GFAP
|
[NCBI]
|
2.71032e-05
|
|
|
HSAN3
|
[NCBI]
|
2.66306e-05
|
|
|
AR
|
[NCBI]
|
2.61499e-05
|
|
|
HGF
|
[NCBI]
|
2.58528e-05
|
|
|
AQP6
|
[NCBI]
|
2.5508e-05
|
|
|
ANGPTL2
|
[NCBI]
|
2.5508e-05
|
|
|
KHDRBS3
|
[NCBI]
|
2.5508e-05
|
|
|
NT5E
|
[NCBI]
|
2.5508e-05
|
|
|
ADM
|
[NCBI]
|
2.40973e-05
|
|
|
SYNPO
|
[NCBI]
|
2.22826e-05
|
|
|
C1QA
|
[NCBI]
|
2.22826e-05
|
|
|
MPV17
|
[NCBI]
|
2.22826e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.20495e-05
|
|
|
LRPAP1
|
[NCBI]
|
2.1099e-05
|
|
|
IL12RB2
|
[NCBI]
|
2.1099e-05
|
|
|
MAF
|
[NCBI]
|
2.1099e-05
|
|
|
SLC9A3R2
|
[NCBI]
|
2.1099e-05
|
|
|
LTBR
|
[NCBI]
|
2.1099e-05
|
|
|
AQP2
|
[NCBI]
|
2.09938e-05
|
|
|
ARPKD
|
[NCBI]
|
2.03774e-05
|
|
|
TCF21
|
[NCBI]
|
2.00888e-05
|
|
|
COL15A1
|
[NCBI]
|
2.00888e-05
|
|
|
PHYH
|
[NCBI]
|
2.00888e-05
|
|
|
NOTCH2
|
[NCBI]
|
2.00888e-05
|
|
|
TNFSF14
|
[NCBI]
|
2.00888e-05
|
|
|
GAS6
|
[NCBI]
|
1.92085e-05
|
|
|
EGFR
|
[NCBI]
|
1.88274e-05
|
|
|
PG
|
[NCBI]
|
1.86732e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.84289e-05
|
|
|
GUCA2B
|
[NCBI]
|
1.77297e-05
|
|
|
NPTX2
|
[NCBI]
|
1.77297e-05
|
|
|
SPP1
|
[NCBI]
|
1.77213e-05
|
|
|
ICOSLG
|
[NCBI]
|
1.70963e-05
|
|
|
SPAM1
|
[NCBI]
|
1.59854e-05
|
|
|
CA4
|
[NCBI]
|
1.54927e-05
|
|
|
HPSE
|
[NCBI]
|
1.54927e-05
|
|
|
CR1
|
[NCBI]
|
1.54927e-05
|
|
|
HNF1B
|
[NCBI]
|
1.54927e-05
|
|
|
VIL2
|
[NCBI]
|
1.50345e-05
|
|
|
HMOX1
|
[NCBI]
|
1.50345e-05
|
|
|
XCL1
|
[NCBI]
|
1.46063e-05
|
|
|
AKR1B1
|
[NCBI]
|
1.39275e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.38266e-05
|
|
|
MAP2K1
|
[NCBI]
|
1.34696e-05
|
|
|
AFP
|
[NCBI]
|
1.27901e-05
|
|
|
MAP3K7
|
[NCBI]
|
1.25055e-05
|
|
|
GSN
|
[NCBI]
|
1.22145e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.2009e-05
|
|
|
TNC
|
[NCBI]
|
1.18956e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.14158e-05
|
|
|
CAV1
|
[NCBI]
|
1.14158e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.14158e-05
|
|
|
GAPDH
|
[NCBI]
|
1.11377e-05
|
|
|
PTH
|
[NCBI]
|
1.07666e-05
|
|
|
HDGF
|
[NCBI]
|
1.071e-05
|
|
|
DCN
|
[NCBI]
|
1.0282e-05
|
|
|
TIMP1
|
[NCBI]
|
9.69342e-06
|
|
|
PKD2
|
[NCBI]
|
9.50985e-06
|
|
|
CXCR4
|
[NCBI]
|
9.33199e-06
|
|
|
LDLR
|
[NCBI]
|
9.10001e-06
|
|
|
SCP2
|
[NCBI]
|
8.67193e-06
|
|
|
PF4
|
[NCBI]
|
8.15091e-06
|
|
|
VHL
|
[NCBI]
|
7.55144e-06
|
|
|
PTHLH
|
[NCBI]
|
7.28516e-06
|
|
|
SLC2A2
|
[NCBI]
|
6.62964e-06
|
|
|
WT1
|
[NCBI]
|
6.58067e-06
|
|
|
CEL
|
[NCBI]
|
6.52551e-06
|
|
|
GDNF
|
[NCBI]
|
6.46338e-06
|
|
|
BBS
|
[NCBI]
|
6.01269e-06
|
|
|
IGFALS
|
[NCBI]
|
5.94402e-06
|
|
|
EPO
|
[NCBI]
|
5.93186e-06
|
|
|
CDK2
|
[NCBI]
|
5.62793e-06
|
|
|
MAPK3
|
[NCBI]
|
5.59297e-06
|
|
|
STC1
|
[NCBI]
|
5.26725e-06
|
|
|
CLU
|
[NCBI]
|
5.11302e-06
|
|
|
TS
|
[NCBI]
|
4.4476e-06
|
|
|
PPARA
|
[NCBI]
|
4.15485e-06
|
|
|
CCL22
|
[NCBI]
|
4.10889e-06
|
|
|
GUSB
|
[NCBI]
|
3.71624e-06
|
|
|
PTEN
|
[NCBI]
|
3.45985e-06
|
|
|
CNTF
|
[NCBI]
|
3.33713e-06
|
|
|
ABCC8
|
[NCBI]
|
3.22132e-06
|
|
|
PLG
|
[NCBI]
|
3.1756e-06
|
|
|
PTN
|
[NCBI]
|
3.08607e-06
|
|
|
DBI
|
[NCBI]
|
2.24549e-06
|
|
|
EGF
|
[NCBI]
|
2.19952e-06
|
|
|
XDH
|
[NCBI]
|
1.7957e-06
|
|
|
FGF2
|
[NCBI]
|
1.74152e-06
|
|
|
TF
|
[NCBI]
|
1.52137e-06
|
|
|
TNF
|
[NCBI]
|
1.47968e-06
|
|
|
ADA
|
[NCBI]
|
1.45831e-06
|
|
|
LCAT
|
[NCBI]
|
9.19095e-07
|
|
|
SST
|
[NCBI]
|
8.86749e-07
|
|
|
PEDF
|
[NCBI]
|
7.36852e-07
|
|
|
APOB
|
[NCBI]
|
7.19977e-07
|
|
|
TLR4
|
[NCBI]
|
6.9735e-07
|
|
|
SOD2
|
[NCBI]
|
5.88391e-07
|
|
|
CP
|
[NCBI]
|
5.69099e-07
|
|
|
TLR2
|
[NCBI]
|
3.72123e-07
|
|
|
FMF
|
[NCBI]
|
3.24142e-07
|
|
|
CDK5
|
[NCBI]
|
1.69272e-07
|
|
|
PTK2
|
[NCBI]
|
1.10156e-07
|
|
|
TG
|
[NCBI]
|
1.01305e-07
|
|
|
LRP1
|
[NCBI]
|
8.48987e-08
|
|
|
TTR
|
[NCBI]
|
7.76816e-08
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.50702e-08
|
|
|
GJA1
|
[NCBI]
|
2.02283e-08
|
|
|
TFPI
|
[NCBI]
|
1.77099e-08
|
|
|
CAT
|
[NCBI]
|
9.46406e-09
|
|
|
STAT3
|
[NCBI]
|
4.71726e-09
|
|